Adverse events and quadrivalent human papillomavirus recombinant vaccine

JAMA. 2009 Dec 23;302(24):2657; author reply 2657-8. doi: 10.1001/jama.2009.1880.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Bias
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Papillomavirus Vaccines / adverse effects*
  • Research Design

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines